Biomedical and digital Health

We are committed to affordable and quality health care. Through efficient development of medicines and personalised lifestyle interventions. Find out more about our knowledge, tools and innovations.

Healthier people with biomedical and digital health

Healthcare costs are rising. We want to do something about it and we can. That is why we are relying on the latest technology, apps and data to make people healthier.

Our latest developments

13 resultaten, getoond 1 t/m 5

ENGAGE: Patient-driven technology for better insight into disease

Informatietype:
Insight
18 September 2023

The newly formed ENGAGE consortium brings together partners from the entire healthcare ecosystem to develop and implement technological solutions that help people with Type 2 Diabetes address meaningful aspects of their health.

Time setters: reduce long waits for new medication with AMS

Informatietype:
Insight
10 August 2023

In this episode, we talk to time setter Wouter Vaes, researcher in microdosing and microtracer studies, about using AMS technology to speed up the development time of new drugs by years.

Ancora Health develops personal diabetes plan with 360 methodology

Informatietype:
Insight
11 May 2023

With the help of TNO's knowledge of diabetic typing, Ancora Health wants to implement a diabetes lifestyle programme within healthcare.

MixMasters uses TNO phenotype test to offer personalised nutrition

Informatietype:
Insight
11 May 2023

TNO is helping MixMasters answer the question 'How can we personalise while remaining user-friendly?' Moreover, during their collaboration, the idea for a new concept was born: FoodiYou.

Personalised Health: Take it personal

Informatietype:
Insight
17 April 2023

TNO helps companies develop scientifically based personalised health applications. Knowledge is translated into applications by using a systems approach, and personalised health is put into practice. An example of this is the collaboration with Gabriele Ronnett of Johnson & Johnson Consumer Health Company.